相关实验视频
Updated: Jun 27, 2025

09:11
Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
6.5K
调查潜在的癌症治疗方法:洞察基因素脱乙酶 (HDACs) 抑制的方法
Basharat Ahmad1, Aamir Saeed2, Ahmed Al-Amery3
1School of Life Science and Technology, Center for Informational Biology, University of Electronics Science and Technology of China, Chengdu 610056, China.
Pharmaceuticals (Basel, Switzerland)
|April 27, 2024
概括
研究人员确定了新的抑制剂,LIG1和LIG2,针对癌症治疗的基因组脱甲基酶 (HDACs). 分子对接和模拟揭示了它们破坏与癌症相关的HDAC酶活性和蛋白质结构的潜力.
科学领域:
- 药用化学 医学化学
- 计算生物学 计算生物学
- 生物化学 生物化学
背景情况:
- 基因组脱乙酶 (HDACs) 是参与癌症发展的关键酶.
- 针对HDACs为各种癌症提供了一个有前途的治疗策略.
研究的目的:
- 发现癌症相关HDAC酶的新型选择性抑制剂.
- 为了研究潜在的HDAC抑制剂的分子机制.
主要方法:
- 使用MOE进行分子对接,以选ZINC数据库化合物与HDAC.
- 分子动力学 (MD) 模拟来分析结合 afinities 和蛋白质 - 连接体相互作用.
- 使用RMSD,RMSF,Rg和主要成分分析 (PCA) 分析蛋白质灵活性.
主要成果:
- 两个稳定的抑制剂,LIG1和LIG2,被确定具有有利的结合.
- MD模拟显示LIG1和LIG2影响HDAC灵活性,并诱导结构变化.
- PCA分析表明,抑制剂活性会改变HDAC的结构动态.
结论:
- LIG1和LIG2显示出作为有效的HDAC抑制剂的潜力.
- 这项研究为进一步研究这些化合物的癌症治疗提供了基础.
- 了解抑制剂诱导的结构动力学是药物设计的关键.
相关概念视频
Spreading of Chromatin Modifications
8.3K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.3K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Histone Modification
13.3K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.3K
Histone Variants at the Centromere
4.3K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.3K

